H. Lundbeck A/S (OTCMKTS:HLUYY – Get Free Report) crossed below its 50-day moving average during trading on Thursday . The stock has a 50-day moving average of $22.00 and traded as low as $22.00. H. Lundbeck A/S shares last traded at $22.00, with a volume of 7,500 shares trading hands.
H. Lundbeck A/S Trading Down 0.0 %
The company has a quick ratio of 0.71, a current ratio of 1.15 and a debt-to-equity ratio of 0.32. The firm has a market capitalization of $21.91 billion, a price-to-earnings ratio of 25.00 and a beta of 0.68. The business has a 50-day moving average of $22.00 and a two-hundred day moving average of $22.00.
H. Lundbeck A/S Company Profile
H. Lundbeck A/S, a biopharmaceutical company, engages in the research, development, production, and sale of pharmaceuticals for the treatment of psychiatric and neurological disorders in Europe, North America, and internationally. The company's principal products include Abilify Maintena for schizophrenia; Brintellix/Trintellix to treat depression; Northera for the treatment of symptomatic neurogenic orthostatic hypotension; Vyepti for migraine prevention; and Rexulti/Rxulti to treat depression/schizophrenia.
Featured Articles
- Five stocks we like better than H. Lundbeck A/S
- What Investors Need to Know to Beat the Market
- Top 3 Investment Themes to Watch for in 2025
- What is Insider Trading? What You Can Learn from Insider Trading
- Mega Buybacks in 2025: Why These 3 Leading Stocks Are Buys
- Unveiling The Power Of VWAP: A Key Indicator For Traders
- AMD vs. NVIDIA: The Better Semiconductor Bet for 2025
Receive News & Ratings for H. Lundbeck A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for H. Lundbeck A/S and related companies with MarketBeat.com's FREE daily email newsletter.